Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 01/12/22
Johnson & Johnson-Microsoft Pact Shows Transformative Potential of Connected HealthcarePYMNTS • 01/11/22
Johnson & Johnson (JNJ) CEO Joaquin Duato at JPMorgan 40th Annual Healthcare Conference (Transcript)Seeking Alpha • 01/10/22
Johnson & Johnson To Spin Off Its Consumer Division and Focus On PharmaceuticalsThe Dog of Wall Street • 01/08/22
Dow Jones Newswires: J&J: Study shows ‘real world evidence' of COVID vaccine's protection against breakthrough infectionMarket Watch • 01/06/22
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United StatesPRNewsWire • 01/06/22
Johnson & Johnson, Shaking Off Its Stodgy Image, Is One of Our Stock Picks for 2022Barrons • 01/01/22
Johnson & Johnson COVID booster offers serious protection against hospitalization from omicron variantCNET • 12/30/21
J&J's COVID-19 vaccine booster was 85% effective against hospitalization, in South Africa studyMarket Watch • 12/30/21
Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was DominantPRNewsWire • 12/30/21